Statistiche accessi

What A Nice Blog!

Notizie interessanti, curiosità, approfondimenti e comunicati stampa by Anicecommunication, agenzia di relazioni con i media e pubbliche relazioni di stanza a Torino, in Italia, ma operante a livello globale grazie a una rete di professionisti della comunicazione parte del network

Vredestein Ultrac Pro: the new ultra-high-performance tyre unrivalled comfort

2024-01-29T10:47:18+00:00Apollo Tyres | Vredestein, Press Room, What A Nice Blog!|

Innovations in structure and materials will give new Vredestein ultra-ultra-high-performance tyre unrivalled comfort. […]

Vredestein Official Main Sponsor of the FIS Alpine World Ski Championships 2025

2024-11-11T16:09:37+00:00Apollo Tyres | Vredestein, Marketing & Social, Press Room, What A Nice Blog!|

New agreement signed by Vredestein Tyres’ parent, Apollo Tyres, applies to FIS Alpine World Ski Championships 2025 being held in Saalbach, Austria, from 4 to 16 February 2025 […]

Moving Intelligence and Echoes join forces to reshape the future of European connected vehicle solutions. 

2024-01-19T15:58:02+00:00Press Room, What A Nice Blog!|

Moving Intelligence, leading the way in secure asset tracking, sustainable fleet management and smart mobility, announces its partnership with Echoes, the recognized leading force in next-generation vehicle data solutions. The combined group will create an undisputed European leader in smart connected vehicle solutions serving customers across 10 European countries with 500,000 connected active assets projected [...]

Apollo Tyres: only a half of UK motorists conduct recommended monthly check of tyre pressures

2024-11-11T16:09:53+00:00Apollo Tyres | Vredestein, Curiosities, Press Room, What A Nice Blog!|

Apollo Tyres survey : Only a half of UK motorists conduct recommended monthly check of tyre pressures […]

Multiple Myeloma: EMN26 Study reported improvements in over 50% patients

2024-11-11T16:55:28+00:00Contents, Curiosities, European Myeloma Network, Press Room, What A Nice Blog!|

EMN26 study on Iberdomide reported substantial response improvements in over 50% of Multiple Myeloma treated patients. […]